Unresectable Malignant Solid Neoplasm Active Not Recruiting Phase 1 Trials for Trastuzumab deruxtecan (DB14962)
Indication | Status | Phase |
---|---|---|
DBCOND0110416 (Unresectable Malignant Solid Neoplasm) | Active Not Recruiting | 1 |
clinicaltrials.gov Identifier | Title | Purpose | Drugs |
---|---|---|---|
NCT04294628 | Testing the Biological Effects of DS-8201a on Patients With Advanced Cancer | Treatment |